We previously showed that solamargine, a steroidal alkaloid glycoside extracted from the traditional Chinese herb Solanum incanum, inhibited the growth of lung cancer cells through inactivation of PI3‐K/Akt signalling pathway, followed by reducing SP1 and p65 expression. Here, SP1 is linked to lung carcinoma.